Gideon Capital Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Gideon Capital Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-29,323	Closed	-$365K	–	571
2016 Q4	$365K	Buy	+29,323	New	+$353K	0.23%	182

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Gideon Capital Advisors's ARIA Position: Q1 2017 in Review

Gideon Capital Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 29,323 shares — an estimated $365K sold.

Gideon Capital Advisors first reported a position in ARIA in Q4 2016 and held it in 1 quarter. The position peaked at $365K in Q4 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Gideon Capital Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Gideon Capital Advisors sold 29,323 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $365K.
Gideon Capital Advisors first reported a position in Ariad Pharmaceuticals Inc in Q4 2016 and held it in 1 quarter.
Gideon Capital Advisors's Ariad Pharmaceuticals Inc position peaked at $365K in Q4 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Gideon Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.